Sitagliptin Tablet, Film Coated
Product Images NDC 60505-3644

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sitagliptin (NDC 60505-3644). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Btl-lbl-100mg-30s (Btl Lbl 100mg 30s)

Sitagliptin Tablets, USP 100 mg film-coated tablets label by Apotex Corp. The label states each tablet contains 128.5 mg sitagliptin phosphate equivalent to 100 mg sitagliptin. The package contains 30 tablets. Storage instructions specify 20°C to 25°C with permitted excursions. Patient dispensing instructions and manufacturer locations in Toronto, Ontario, Canada and Weston, Florida are included.*

FDA Label Image

Btl-lbl-100mg-90s (Btl Lbl 100mg 90s)

Label for Sitagliptin Tablets, USP 100 mg film-coated tablets by Apotex Corp. The label indicates a package count of 90 tablets. It includes storage instructions, the National Drug Code (NDC 60505-3645-9), and manufacturing information for Apotex Inc., Toronto, Canada. The label also features a barcode and a reference to the pharmacist for medication guide dispensing.*

FDA Label Image

Btl-lbl-25mg-30s (Btl Lbl 25mg 30s)

Label for Sitagliptin Tablets, USP 25 mg film-coated tablets, containing 32.13 mg sitagliptin phosphate equivalent to 25 mg sitagliptin. Package contains 30 tablets. Manufactured by Apotex Inc., Toronto, Ontario, Canada, and labeled by Apotex Corp., Weston, Florida. The label includes storage instructions, prescribing note to see the package insert, and a barcode.*

FDA Label Image

Btl-lbl-25mg-90s (Btl Lbl 25mg 90s)

Label for Sitagliptin Tablets, USP 25 mg film-coated tablets, oral use. The package contains 90 tablets. Labeler is Apotex Corp. Manufactured by Apotex Inc., Toronto, Ontario, Canada. The label includes storage instructions, an NDC code 60505-3643-9, and a barcode. There is a pink stripe indicating the 25 mg strength and a small image of a tablet marked with 'S 25'.*

FDA Label Image

Btl-lbl-50mg-30s (Btl Lbl 50mg 30s)

Sitagliptin Tablets USP 50 mg film-coated oral tablets packaging label. The label indicates a quantity of 30 tablets with NDC 60505-3644-3. Manufactured by Apotex Inc., Toronto, Canada and labeled for Apotex Corp., Weston, Florida. Storage instructions and a pharmacist medication guide link are also included.*

FDA Label Image

Btl-lbl-50mg-90s (Btl Lbl 50mg 90s)

Label for Sitagliptin Tablets, USP 50 mg film-coated tablets. The label states 90 tablets per container and includes storage instructions to keep between 20°C to 25°C with allowed excursions. Manufactured by Apotex Inc. in Toronto, Canada, for Apotex Corp. in Weston, Florida. The label includes a barcode, NDC 60505-3644-9, and pharmacist dispensing information.*

FDA Label Image

Figure1 (Figure1)

A line graph depicting LS mean change from baseline over 24 weeks for various treatments including placebo, Sitagliptin 100 mg q.d., Metformin 500 mg b.i.d., Metformin 1000 mg b.i.d., and combinations of Sitagliptin 50 mg b.i.d. with Metformin 500 mg b.i.d. or 1000 mg b.i.d., showing changes measured weekly.*

FDA Label Image

Figure2 (Figure2)

A line graph comparing the least squares (LS) mean change from baseline over 52 weeks for Sitagliptin 100 mg and Glipizide. The x-axis represents weeks from 0 to 52, and the y-axis shows LS mean change from baseline from 0.0 to -1.5. Sitagliptin data points are marked with diamonds and Glipizide with circles. Both treatments show a decline initially, with values leveling off between weeks 12 and 30, followed by a slight increase toward week 52.*

FDA Label Image

Chemical-structure (Sitagliptin 01)

Chemical structure of sitagliptin, showing its molecular components including trifluoromethyl, fluorophenyl groups, and phosphate and water molecules as indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.